Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer

Fertility and Sterility

Volumn 93, Issue 2, 2010, Pages 554-569

  Mitwally, Mohamed F ^a   Diamond, Michael P ^b   Abuzeid, Mostafa ^c  

^a Division of Reproductive Endocrinology and Infertility   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

IM P4; in vitro fertilization; luteal support; micronized vaginal progesterone

Indexed keywords

PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; DRUG BLOOD LEVEL; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; PREGNANCY RATE; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ADULT; CHORIONIC GONADOTROPIN; COHORT STUDIES; CORPUS LUTEUM; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; OOCYTE RETRIEVAL; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROGESTERONE; RETROSPECTIVE STUDIES; VAGINA; YOUNG ADULT;

EID: 74449093910     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.047     Document Type: Article

References (60)

1. Muasher S.J., Abdallah R.T., and Hubayter Z.R. Optimal stimulation protocols for in vitro fertilization. Fertil Steril 86 (2006) 267-273
2. Karande V.C., Korn A., Morris R., Rao R., Balin M., Rinehart J., et al. Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility. Fertil Steril 71 (1999) 468-475
3. Soliman S., Daya S., Collins J., and Jarrell J. A randomized trial of in vitro fertilization versus conventional treatment for infertility. Fertil Steril 59 (1993) 1239-1244
4. Hughes E.G., Federkow D.M., Daya S., Sagle M.A., Van De Koppel P., and Collins J.A. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 58 (1992) 888-896
5. Gomel V., and Cheung P.C.K. Vitro Fertilization and Assisted Reproduction (1997), Monsuzzi Editor, Bologna 405-15
6. de Mouzon J, Lancaster PI. World Collaborative Report on In Vitro Fertilization-1993. XVth World Congress on Fertility and Sterility 1995; Montpellier, September, 17-22.
7. Jones Jr. H.W., Jones G.S., Andrews M.C., Acosta A., Bundren C., Garcia J., et al. The program for in vitro fertilization at Norfolk. Fertil Steril 38 (1982) 14-21
8. Csapo A.I., Pulkkinen M.O., Ruttner B., Sauvage J.P., and Wiest W.G. The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies. Am J Obstet Gynecol 112 (1972) 1061-1067
9. Csapo A.I., Pulkkinen M.O., and Wiest W.G. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. Am J Obstet Gynecol 115 (1973) 759-765
10. The Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society for Reproductive Endocrinology and Infertility. Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin. Fertil Steril 5 (2008) S150-S153
11. Fatemi H.M., Popovic-Todorovic B., Papanikolaou E., Donoso P., and Devroey P. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 13 (2007) 581-590
12. Penzias A. Luteal phase support. Fertil Steril 77 (2002) 318-323
13. Carson D.D., Baqchi I., Dey S.K., Enders A.C., Fazleabas A.T., Lessey B.A., et al. Embryo implantation. Dev Biol 223 (2000) 217-237
14. Edwards R.G., Steptoe P.C., and Purdy J.M. Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 87 (1980) 737-756
15. Jones G.S. Luteal phase defect: a review of pathophysiology. Curr Opin Obstet Gynecol 3 (1991) 641-648
16. Casper R.F., and Yen S.S. Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor. Science 205 (1979) 408-410
17. Smitz J., Erard P., Camus M., Devroey P., Tournaye H., Wisanto A., et al. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Hum Reprod 7 (1992) 1225-1229
18. Smitz J., Bourgain C., Van Waesberghe L., Camus M., Devroey P., and Van Steirteghem A.C. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG-induced superovulation. Hum Reprod 8 (1993) 40-45
19. Fauser B.C., and Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 14 (2003) 236-242
20. Kerin J.F., Broom T.J., Ralph M.M., et al. Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles. Br J Obstet Gynaecol 88 (1981) 1021-1028
21. Mochtar M.H., Hogerzeil H.V., and Mol B.W. Progesterone alone versus progesterone combined with hCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial. Hum Reprod 11 (1996) 1602-1605
22. Hutchins-Williams K.A., Decherney A.H., Lavy G., Diamond M.P., Naftolin F., and Lunenfeld B. Luteal rescue in in vitro fertilization-embryo transfer. Fertil Steril 53 (1990) 495-501
23. Daya S., and Gunby J. Luteal phase support in assisted reproduction cycles [Review]. Cochrane Database Syst Rev 3 (2004) CD004830
24. Propst A.M., Hill J.A., Ginsburg E.S., Hurwitz S., Politch J., and Yanushpolsky E.H. A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertil Steril 76 (2001) 1144-1149
25. Miles R.A., Paulson R.J., Lobo R.A., Press M.F., Dahmoush L., and Sauer M.V. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril 62 (1994) 485-490
26. Preston R.A., Norris P.M., Blake E.J., and Yankov V.I. Single day and multiple day pharmacokinetics of a novel vaginal micronized progesterone tablet (Endometrin) compared to Crinone vaginal gel in healthy female subjects. Reprod Sci 14 (2007) 198A
27. Doody KJ, Schnell VL, Foulk RA, Miller CE, Kolb BA, Blake EJ, et al. Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation. Fertil Steril. Published online April 18, 2008 [Epub ahead of print].
28. Pritts E.A., and Atwood A.K. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 17 (2002) 2287-2299
29. Lightman A., Kol S., and Itskovitz-Eldor J. A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles. Hum Reprod 14 (1999) 2596-2599
30. Bouckaert Y., Robert F., Englert Y., De Backer D., De Vuyst P., and Delbaere A. Acute eosinophilic pneumonia associated with intramuscular administration of progesterone as luteal phase support after IVF: case report. Hum Reprod 19 (2004) 1806-1810
31. Kimzey L.M., Gumowski J., Merriam G.R., Grimes Jr. G.J., and Nelson L.M. Absorption of micronized progesterone from a nonliquifying vaginal cream. Fertil Steril 56 (1999) 995-996
32. Cicinelli E., Schonauer L.M., Galantino P., Matteo M.G., Cassetta R., and Pinto V. Mechanisms of uterine specificity of vaginal progesterone. Hum Reprod 15 (2000) 159-165
33. de Ziegler D., Seidler L., Scharer E., and Bouchard P. Non-oral administration of progesterone: experiences and possibilities of the transvaginal route. Schweiz Rundsch Med Prax 84 (1995) 127-133
34. Channing C.P., Schaerf F.W., Anderson L.D., and Tsafriri A. Ovarian follicular and luteal physiology. Int Rev Physiol 22 (1980) 117-201
35. Leung P.C., and Armstrong D.T. Interactions of steroids and gonadotropins in the control of steroidogenesis in the ovarian follicle. Ann Rev Physiol 42 (1980) 71-82
36. Mahesh V.B. The dynamic interaction between steroids and gonadotropins in the mammalian ovulatory cycle. Neurosci Biobehav Rev 9 (1985) 245-260
37. Rothchild I. Regulation of the mammalian corpus luteum. Recent Prog Horm Res 37 (1981) 183-298
38. Stocco C., Telleria C., and Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr Rev 28 (2007) 117-149
39. Cowan B.D., Whitworth N.S., Sopelak V.M., Isaacs J.D., and Long C.A. Regulation of early gestational corpus luteum function in spontaneous and follicular stimulated conceptions. Fertil Steril 62 (1994) 263-268
40. Artini P.G., Volpe A., Angioni S., Galassi M.C., Battaglia C., and Genazzani A.R. A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program. J Endocrinol Invest 18 (1995) 51-56
41. Abate A., Perino M., Abate F.G., Brigandi A., Costabile L., and Manti F. Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer: a comparative randomized study. Clin Exp Obstet Gynecol 26 (1999) 203-206
42. Anserini P., Costa M., Remorgida V., Sarli R., Guglielminetti E., and Ragni N. Luteal phase support in assisted reproductive cycles using either vaginal (Crinone 8%) or intramuscular (Prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol 53 (2001) 297-301
43. Levine H. Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers. Fertil Steril 74 (2000) 836-837
44. Simunic V., Tomic V., Tomic J., and Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal phase support. Fertil Steril 87 (2007) 83-87
45. Ludwig M., Schwartz P., Babahan B., Katalinic A., Weiss J.M., Felberbaum R., et al. Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study. Eur J Obstet Gynecol Reprod Biol 103 (2002) 48-52
46. Ng E.H., Chan C.C., Tang O.S., and Ho P.C. A randomized comparison of side effects and patient convenience between Cyclogest suppositories and Endometrin tablets used for luteal phase support in IVF treatment. Eur J Obstet Gynecol Reprod Biol 131 (2007) 182-188
47. Yanushpolsky E., Hurwitz S., Greenberg L., Racowsky C., and Hornstein M.D. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. Fertil Steril 89 (2008) 485-487
48. Witz C.A., and Burns W.N. Endometriosis and infertility: is there a cause and effect relationship?. Gynecol Obstet Invest 53 Suppl 1 (2002) 2-11
49. Attia G.R., Zeitoun K., Edwards D., Johns A., Carr B.R., and Bulun S.E. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 85 (2000) 2897-2902
50. Cahill D.J., and Hull M.G. Pituitary-ovarian dysfunction and endometriosis. Hum Reprod Update 6 (2000) 56-66
51. Cunha-Filho J.S., Gross J.L., Bastos de Souza C.A., Lemos N.A., Giugliani C., Freitas F., et al. Physiopathological aspects of corpus luteum defect in infertile patients with mild/minimal endometriosis. J Assist Reprod Genet 20 (2003) 117-121
52. Donaghay M., and Lessey B.A. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med 25 (2007) 461-475
53. Kyama C.M., Overbergh L., Mihalyi A., Meuleman C., Mwenda J.M., Mathieu C., et al. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril 89 (2008) 301-310
54. Sallam H.N., Garcia-Velasco J.A., Dias S., and Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 25 (2006) CD004635
55. Cirigliano M. Bioidentical hormone therapy: a review of the evidence. J Womens Health (Larchmt) 16 (2007) 600-631
56. Boothby L.A., and Doering P.L. Bioidentical hormone therapy: a panacea that lacks supportive evidence. Curr Opin Obstet Gynecol 20 (2008) 400-407
57. Mahaguna V., McDermott J.M., Zhang F., and Ochoa F. Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel. Drug Dev Ind Pharm 30 (2004) 1069-1078
58. A response to the Wyeth petition. Available at http://www.iacprx.org/site/DocServer/APhA_Comments_on_2005P-0411.pdf?docID=1601.
59. Filicori M., Butler J.P., and Crowley Jr. W.F. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 73 (1984) 1638-1647
60. Khan N, Richter KS, Newsome TL, Blake EJ, Yankov VI. Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer. Fertil Steril. Published online June 13, 2008 [Epub ahead of print].